Get the Stockscreener App
1.1699
1.71%
0.0197
After Hours:
1.17
0.000100
+0.01%
Therapeuticsmd Inc stock is traded at $1.1699, with a volume of 32,868.
It is up +1.71% in the last 24 hours and up +3.07% over the past month.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
See More
Previous Close:
$1.1502
Open:
$1.15
24h Volume:
32,868
Relative Volume:
0.86
Market Cap:
$13.54M
Revenue:
$996.00K
Net Income/Loss:
$-6.09M
P/E Ratio:
-2.2074
EPS:
-0.53
Net Cash Flow:
$-9.76M
1W Performance:
+10.23%
1M Performance:
+3.07%
6M Performance:
+13.58%
1Y Performance:
-27.34%
1-Day Range:
$1.11
$1.18
1-Week Range:
$1.07
$1.18
52-Week Range:
$0.70
$2.44
Therapeuticsmd Inc Stock (TXMD) Company Profile
Name
Therapeuticsmd Inc
Sector
Phone
561-961-1900
Address
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
Compare TXMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TXMD
Therapeuticsmd Inc
|
1.1699 | 13.31M | 996.00K | -6.09M | -9.76M | -0.53 |
|
ZTS
Zoetis Inc
|
154.11 | 67.83B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.00 | 46.74B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.65 | 43.52B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.86 | 20.12B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
313.13 | 14.11B | 2.99B | 1.21B | 1.13B | 25.06 |
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-07-20 | Downgrade | Jefferies | Hold → Underperform |
| May-19-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-02-19 | Initiated | Guggenheim | Buy |
| Oct-17-19 | Initiated | H.C. Wainwright | Buy |
| Apr-30-19 | Resumed | Noble Capital Markets | Outperform |
| Jun-15-18 | Initiated | JP Morgan | Overweight |
| Sep-08-17 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-11-17 | Upgrade | Oppenheimer | Perform → Outperform |
| May-09-17 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-22-16 | Resumed | Jefferies | Buy |
| Nov-22-16 | Initiated | Oppenheimer | Outperform |
| Nov-07-16 | Resumed | Guggenheim | Buy |
| Apr-04-16 | Initiated | Goldman | Buy |
| Dec-08-15 | Reiterated | Jefferies | Buy |
| Dec-08-15 | Reiterated | Stifel | Buy |
| Sep-21-15 | Reiterated | Jefferies | Buy |
| Jun-09-15 | Initiated | Guggenheim | Buy |
| Jul-08-14 | Initiated | FBR Capital | Outperform |
| Apr-17-14 | Reiterated | Noble Financial | Buy |
| Jan-28-14 | Reiterated | Noble Financial | Buy |
View All
Therapeuticsmd Inc Stock (TXMD) Latest News
Using fundamentals and technicals on TherapeuticsMD Inc.Market Sentiment Report & Technical Analysis for Trade Confirmation - Newser
Leading vs lagging indicators on TherapeuticsMD Inc. performancePortfolio Gains Report & Real-Time Volume Spike Alerts - Newser
What’s the recovery path for long term holders of TherapeuticsMD Inc.2025 Market Trends & Long Hold Capital Preservation Plans - Newser
Signal strength of TherapeuticsMD Inc. stock in tech scannersWeekly Risk Report & Weekly Top Gainers Trade List - Newser
Can volume confirm reversal in TherapeuticsMD Inc.July 2025 Closing Moves & Safe Entry Point Identification - Newser
Will breakout in TherapeuticsMD Inc. lead to full recoveryDay Trade & AI Forecasted Entry/Exit Points - Newser
Analyzing drawdowns of TherapeuticsMD Inc. with statistical toolsMarket Growth Review & Weekly Return Optimization Alerts - Newser
Is it time to cut losses on TherapeuticsMD Inc.2025 Fundamental Recap & Capital Protection Trade Alerts - Newser
Has TherapeuticsMD Inc. formed a bullish divergence2025 Risk Factors & Weekly Setup with ROI Potential - Newser
How TherapeuticsMD Inc. stock performs during market volatilityJuly 2025 Selloffs & Risk Managed Investment Strategies - Newser
Does TherapeuticsMD Inc. qualify in momentum factor screeningSell Signal & AI Enhanced Trade Execution Alerts - Newser
Market reaction to TherapeuticsMD Inc.’s recent newsJuly 2025 Patterns & Real-Time Volume Trigger Notifications - Newser
Is TherapeuticsMD Inc. stock ready for a breakoutGap Down & Long-Term Safe Investment Plans - Newser
Using data tools to time your TherapeuticsMD Inc. exitMarket Sentiment Review & Verified Technical Trade Signals - Newser
What recovery options are there for TherapeuticsMD Inc.Watch List & Weekly Breakout Stock Alerts - Newser
Custom watchlist performance reports with TherapeuticsMD Inc.Trade Volume Report & Weekly Setup with ROI Potential - Newser
Published on: 2025-08-15 14:51:17 - Newser
Using flow based indicators on TherapeuticsMD Inc.Market Growth Report & Technical Entry and Exit Alerts - Newser
How to interpret RSI for TherapeuticsMD Inc. stockRate Cut & Weekly Market Pulse Updates - Newser
Regression analysis insights on TherapeuticsMD Inc. performance2025 Big Picture & Daily Stock Trend Watchlist - Newser
TherapeuticsMD Swings to Profit in Q2 - AOL.com
Analyzing TherapeuticsMD Inc. with risk reward ratio charts2025 Technical Patterns & Consistent Profit Trade Alerts - Newser
Is TherapeuticsMD Inc.’s ROE strong enoughJobs Report & Free Fast Gain Swing Trade Alerts - thegnnews.com
Developing predictive dashboards with TherapeuticsMD Inc. dataTrade Analysis Report & Free Low Drawdown Momentum Trade Ideas - Newser
TherapeuticsMD Inc. Company’s Quarterly Earnings Growth: What the Numbers SayJuly 2025 Movers & Breakout Confirmation Trade Signals - Newser
What makes TherapeuticsMD Inc. stock price move sharplyJuly 2025 Institutional & Consistent Profit Alerts - Newser
TherapeuticsMD: Q2 Earnings Snapshot - Stamford Advocate
TherapeuticsMD Reports Q2 2025 Financial Results - MSN
Will TherapeuticsMD Inc. rebound enough to break evenJuly 2025 Update & AI Driven Price Predictions - Newser
TherapeuticsMD Reports Q2 Profitability, Exceeding 2024 Results - AInvest
TherapeuticsMD Announces Second Quarter 2025 Financial Results - BioSpace
Therapeuticsmd 2025 Q2 Earnings Strong Performance as Net Income Surges 150.6% - AInvest
TherapeuticsMD Inc. Rebounds From Oversold Zone — Now WhatConsistent Income Focused Trade List Analyzed - beatles.ru
Therapeuticsmd Inc Stock (TXMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.80%
0.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):